Psychosocial functioning and health related quality of life in children, adolescents and young adults with type 1 diabetes mellitus in Congo.

Autor:	Missambou Mandilou SV; Department of Pediatrics, Teaching Hospital of Brazzaville, Brazzaville, Congo.; Institut du Diabète Maison Bleue of Brazzaville, Brazzaville, Congo., Atipo-Ibara Ollandzobo LC; Department of Pediatrics, Teaching Hospital of Brazzaville, Brazzaville, Congo.; Department of Medicine, Health Sciences Faculty, Marien Ngouabi University, Brazzaville, Congo., Kitemo Mpolo FLG; Department of Pediatrics, Teaching Hospital of Brazzaville, Brazzaville, Congo., Ngoulou BPS; Department of Pediatrics, Teaching Hospital of Brazzaville, Brazzaville, Congo., Elenga Bongo CL; Department of Medicine, Health Sciences Faculty, Marien Ngouabi University, Brazzaville, Congo.; Department of Metabolic and Endocrine Diseases, General Hospital Adolph Sicé, Pointe-Noire, Congo., Bouénizabila E; Institut du Diabète Maison Bleue of Brazzaville, Brazzaville, Congo.; Department of Medicine, Health Sciences Faculty, Marien Ngouabi University, Brazzaville, Congo.; Department of Metabolic and Endocrine Diseases, Teaching Hospital of Brazzaville, Brazzaville, Congo., Mabiala Babela JR; Department of Pediatrics, Teaching Hospital of Brazzaville, Brazzaville, Congo.; Department of Medicine, Health Sciences Faculty, Marien Ngouabi University, Brazzaville, Congo.
Jazyk:	angličtina
Zdroj:	Pediatric diabetes [Pediatr Diabetes] 2021 Jun; Vol. 22 (4), pp. 675-682. Date of Electronic Publication: 2021 Feb 15.
DOI:	10.1111/pedi.13187
Abstrakt:	Objectives: To describe the psychosocial functioning and assess the quality of life of children, adolescents and young adults with T1DM; and to identify the risk factors associated with the psychosocial experience and quality of life of these patients. Material and Methods: A cross-sectional, descriptive study of children, adolescents and young adults with type 1 diabetes. Symptoms of anxiety and depression, and the quality of life were assessed using the Beck's Anxiety and Depression Scales and the pedsQL diabetes module score respectively. Results: A total of 74 patients were recruited. The mean age was 18 ± 4.1 years. Minimal symptoms of anxiety were noted in 51 (69%) patients, 23 (31%) had non-minimal symptoms of anxiety (mild:14, moderate: 5, severe: 4). Symptoms of depression were absent in 43 (58.1%) patients and present in 31 (41.9%) patients (mild: 19, moderate: 12). The patients total score of quality of life was 65.4. Higher socioeconomic status (p = 0.03) was a protective factor against Symptoms of anxiety, while the age above 14 years (p = 0.01) was a risk factor for symptoms of depression. The quality of life was lower in patients from low socio-economic status (p = 0.01), those with poor glycemic control (p = 0.03), and when symptoms of depression were present (p = 0.02). Conclusions: Patients with type 1 diabetes in Congo experienced a significant elevated symptoms of anxiety and depression, and a fairly good quality of life. These findings support recommendations for integrating psychosocial aspects in the management of these patients. (© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu